Global Global Cell Viability Assays Market Size, Share, Analysis, Trends, Growth, 2032
Cell Viability Assays Market By Product (Consumables and Instruments), By Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Others), By End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 14.21 Billion | USD 31.61 Billion | 9.29% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global cell viability assays market, 2016-2025 (USD Billion)
- 2.2. Global cell viability assays market: Snapshot
- Chapter 3. Cell Viability Assays Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global cell viability assays market drivers: Impact analysis
- 3.2.2. Rising Incidence and Prevalence of Chronic and Infectious Diseases
- 3.2.3. Growing Availability of Funds for Research
- 3.2.4. Rising Demand for Cell-Based Assays in Research
- 3.2.5. Increasing Focus on the Development of Cell-Based Therapeutics
- 3.3. Market Restraints
- 3.3.1. Global cell viability assays market restraints: Impact analysis
- 3.3.2. High Cost of Instruments
- 3.4. Opportunities
- 3.4.1. Emerging Markets
- 3.4.2. Growing Focus on Stem Cell Research
- 3.5. Porter's Five Forces analysis
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by product
- 3.6.2. Market attractiveness analysis, by application
- 3.6.3. Market attractiveness analysis, by end-user
- 3.6.4. Market attractiveness analysis, by region
- Chapter 4. Global Cell Viability Assays Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global cell viability assays market: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New instruments launch
- 4.2.3. Agreements, partnerships, collaborations, and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Cell Viability Assays Market - Product Analysis
- 5.1. Global cell viability assays market: Product overview
- 5.1.1. Global cell viability assays market revenue share, by product, 2018 and 2025
- 5.2. Consumables
- 5.2.1. Global cell viability assays market for consumables, 2016-2025 (USD Billion)
- 5.3. Instruments
- 5.3.1. Global cell viability assays market for instruments, 2016-2025 (USD Billion)
- 5.1. Global cell viability assays market: Product overview
- Chapter 6. Global Cell Viability Assays Market - Application Analysis
- 6.1. Global cell viability assays market: Application overview
- 6.1.1. Global cell viability assays market revenue share, by application, 2018 and 2025
- 6.2. Basic Research
- 6.2.1. Global cell viability assays market for basic research, 2016-2025 (USD Billion)
- 6.3. Stem Cell Research
- 6.3.1. Global cell viability assays market for stem cell research, 2016-2025 (USD Billion)
- 6.4. Drug Discovery & Development
- 6.4.1. Global cell viability assays market for drug discovery & development, 2016-2025 (USD Billion)
- 6.5. Clinical & Diagnostic Applications
- 6.5.1. Global cell viability assays market for clinical and diagnostic applications, 2016-2025 (USD Billion)
- 6.6. Others
- 6.6.1. Global cell viability assays market for others, 2016-2025 (USD Billion)
- 6.1. Global cell viability assays market: Application overview
- Chapter 7. Global Cell Viability Assays Market - End-User Analysis
- 7.1. Global cell viability assays market: End-User overview
- 7.1.1. Global cell viability assays market revenue share, by End-User, 2018 and 2025
- 7.2. Academic and Research Institutes
- 7.2.1. Global cell viability assays market for academic and research institutes, 2016-2025 (USD Billion)
- 7.3. Pharmaceutical and Biotechnology Companies
- 7.3.1. Global cell viability assays market for pharmaceutical and biotechnology companies, 2016-2025 (USD Billion)
- 7.4. Hospitals and Diagnostic Laboratories
- 7.4.1. Global cell viability assays market for hospitals and diagnostic laboratories, 2016-2025 (USD Billion)
- 7.5. Others
- 7.5.1. Global cell viability assays market for others, 2016-2025 (USD Billion)
- 7.1. Global cell viability assays market: End-User overview
- Chapter 8. Global Cell Viability Assays Market - Regional Analysis
- 8.1. Global cell viability assays market: Regional overview
- 8.1.1. Global cell viability assays market revenue share, by region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America cell viability assays market, 2016-2025 (USD Billion)
- 8.2.2. North America cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.2.3. North America cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.2.4. North America cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.2.5. The U.S.
- 8.2.5.1. The U.S. cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.2.5.2. The U.S. cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.2.5.3. The U.S. cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.2.6. Canada
- 8.2.6.1. Canada cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.2.6.2. Canada cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.2.6.3. Canada cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe cell viability assays market, 2016-2025 (USD Billion)
- 8.3.2. Europe cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.3.2.1. Europe cell viability assays market revenue, by consumables, 2016-2025 (USD Billion)
- 8.3.3. Europe cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.3.4. Europe cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.3.5. UK
- 8.3.5.1. UK cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.3.5.2. UK cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.3.5.3. UK cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.3.6. Germany
- 8.3.6.1. Germany cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.3.6.2. Germany cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.3.6.3. Germany cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.3.7. France
- 8.3.7.1. France cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.3.7.2. France cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.3.7.3. France cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of Europe cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.3.8.2. Rest of Europe cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.3.8.3. Rest of Europe cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific cell viability assays market, 2016-2025 (USD Billion)
- 8.4.2. Asia Pacific cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.4.3. Asia Pacific cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.4.4. Asia Pacific cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.4.5. China
- 8.4.5.1. China cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.4.5.2. China cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.4.5.3. China cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.4.6. Japan
- 8.4.6.1. Japan cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.4.6.2. Japan cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.4.6.3. Japan cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.4.7. India
- 8.4.7.1. India cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.4.7.2. India cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.4.7.3. India cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.4.8.2. Rest of Asia Pacific cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.4.8.3. Rest of Asia Pacific cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America cell viability assays market, 2016-2025 (USD Billion)
- 8.5.2. Latin America cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.5.3. Latin America cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.5.4. Latin America cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.5.5. Brazil
- 8.5.5.1. Brazil cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.5.5.2. Brazil cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.5.5.3. Brazil cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.5.6.2. Rest of Latin America cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.5.6.3. Rest of Latin America cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa cell viability assays market, 2016-2025 (USD Billion)
- 8.6.2. The Middle East and Africa cell viability assays market revenue, by product, 2016-2025 (USD Billion)
- 8.6.3. The Middle East and Africa cell viability assays market revenue, by application, 2016-2025 (USD Billion)
- 8.6.4. The Middle East and Africa cell viability assays market revenue, by End-User, 2016-2025 (USD Billion)
- 8.1. Global cell viability assays market: Regional overview
- Chapter 9. Company Profile
- 9.1. GE Healthcare
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. Bio-Rad Laboratories, Inc.
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. PerkinElmer
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. Danaher Corporation
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. Promega Corporation
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Developments
- 9.6. Thermo Fischer Scientific
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Developments
- 9.7. BioTek Instruments
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Developments
- 9.8. Biotium
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Developments
- 9.9. Becton, Dickinson, and Company
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Developments
- 9.10. G-Biosciences
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Developments
- 9.11. Merck
- 9.11.1. Overview
- 9.11.2. Financials
- 9.11.3. Product Portfolio
- 9.11.4. Business Strategy
- 9.11.5. Recent Developments
- 9.1. GE Healthcare
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global cell viability assays market revenue, 2016–2025 (USD Billion)
4. Porter’s Five Forces analysis
5. Cell Viability Assays market attractiveness analysis, by product
6. Cell Viability Assays market attractiveness analysis, by application
7. Cell Viability Assays market attractiveness analysis, by End-User
8. Cell Viability Assays market: market attractiveness analysis, by region
9. Company market share analysis, 2018
10. Global cell viability assays market revenue share by product, 2018 and 2025
11. Global cell viability assays market for consumables, 2016–2025 (USD Billion)
12. Global cell viability assays market for instruments, 2016–2025 (USD Billion)
13. Global cell viability assays market revenue share by application, 2018 and 2025
14. Global cell viability assays market for basic research, 2016–2025 (USD Billion)
15. Global cell viability assays market for stem cell research, 2016–2025 (USD Billion)
16. Global cell viability assays market for drug discovery & development, 2016–2025 (USD Billion)
17. Global cell viability assays market for clinical & diagnostic applications, 2016–2025 (USD Billion)
18. Global cell viability assays market for others, 2016–2025 (USD Billion)
19. Global cell viability assays market revenue share by End-User, 2018 and 2025
20. Global cell viability assays market for academic and research institutes, 2016–2025 (USD Billion)
21. Global cell viability assays market for pharmaceutical and biotechnology companies, 2016–2025 (USD Billion)
22. Global cell viability assays market for hospitals and diagnostic laboratories, 2016–2025 (USD Billion)
23. Global cell viability assays market for others, 2016–2025 (USD Billion)
24. North America cell viability assays market, 2016–2025 (USD Billion)
25. Europe cell viability assays market, 2016–2025 (USD Billion)
26. Asia Pacific cell viability assays market, 2016–2025 (USD Billion)
27. Latin America cell viability assays market, 2016–2025 (USD Billion)
28. The Middle East and Africa cell viability assays market, 2016–2025 (USD Billion)
Table Of Tables
List of Tables
1. Global cell viability assays market: Market Snapshot
2. Drivers of global cell viability assays market: Impact analysis
3. Restraints of global cell viability assays market: Impact analysis
4. North America cell viability assays market revenue, by product, 2016–2025 (USD Billion)
5. North America cell viability assays market revenue, by application, 2016–2025 (USD Billion)
6. North America cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
7. The U.S. cell viability assays market revenue, by product, 2016–2025 (USD Billion)
8. The U.S. cell viability assays market revenue, by application, 2016–2025 (USD Billion)
9. The U.S. cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
10. Canada cell viability assays market revenue, by product, 2016–2025 (USD Billion)
11. Canada cell viability assays market revenue, by application, 2016–2025 (USD Billion)
12. Canada cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
13. Europe cell viability assays market revenue, by product, 2016–2025 (USD Billion)
14. Europe cell viability assays market revenue, by application, 2016–2025 (USD Billion)
15. Europe cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
16. UK cell viability assays market revenue, by product, 2016–2025 (USD Billion)
17. UK cell viability assays market revenue, by application, 2016–2025 (USD Billion)
18. UK cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
19. Germany cell viability assays market revenue, by product, 2016–2025 (USD Billion)
20. Germany cell viability assays market revenue, by application, 2016–2025 (USD Billion)
21. Germany cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
22. France cell viability assays market revenue, by product, 2016–2025 (USD Billion)
23. France cell viability assays market revenue, by application, 2016–2025 (USD Billion)
24. France cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
25. Rest of Europe cell viability assays market revenue, by product, 2016–2025 (USD Billion)
26. Rest of Europe cell viability assays market revenue, by application, 2016–2025 (USD Billion)
27. Rest of Europe cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
28. Asia Pacific cell viability assays market revenue, by product, 2016–2025 (USD Billion)
29. Asia Pacific cell viability assays market revenue, by application, 2016–2025 (USD Billion)
30. Asia Pacific cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
31. China cell viability assays market revenue, by product, 2016–2025 (USD Billion)
32. China cell viability assays market revenue, by application, 2016–2025 (USD Billion)
33. China cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
34. Japan cell viability assays market revenue, by product, 2016–2025 (USD Billion)
35. Japan cell viability assays market revenue, by application, 2016–2025 (USD Billion)
36. Japan cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
37. India cell viability assays market revenue, by product, 2016–2025 (USD Billion)
38. India cell viability assays market revenue, by application, 2016–2025 (USD Billion)
39. India cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
40. Rest of Asia Pacific cell viability assays market revenue, by product, 2016–2025 (USD Billion)
41. Rest of Asia Pacific cell viability assays market revenue, by application, 2016–2025 (USD Billion)
42. Rest of Asia Pacific cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
43. Latin America cell viability assays market revenue, by product, 2016–2025 (USD Billion)
44. Latin America cell viability assays market revenue, by application, 2016–2025 (USD Billion)
45. Latin America cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
46. Brazil cell viability assays market revenue, by product, 2016–2025 (USD Billion)
47. Brazil cell viability assays market revenue, by application, 2016–2025 (USD Billion)
48. Brazil cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
49. Rest of Latin America cell viability assays market revenue, by product, 2016–2025 (USD Billion)
50. Rest of Latin America cell viability assays market revenue, by application, 2016–2025 (USD Billion)
51. Rest of Latin America cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
52. The Middle East and Africa cell viability assays market revenue, by product, 2016–2025 (USD Billion)
53. The Middle East and Africa cell viability assays market revenue, by application, 2016–2025 (USD Billion)
54. The Middle East and Africa cell viability assays market revenue, by End-User, 2016–2025 (USD Billion)
Methodology
FrequentlyAsked Questions
Cell viability assays are experimental techniques used to measure the amount of healthy, living cells in a sample and assess their overall health and function. These assays evaluate cell survival and metabolic activity after experimental treatments, medications, or environmental factors and are essential in biomedical research, drug development, and toxicology.
The global cell viability assays market is driven by the rising prevalence of chronic and infectious diseases, increasing investments in drug development and cell-based research, advancements in assay technologies such as automation and high-content imaging, and growing emphasis on personalized medicine and regenerative therapies.
According to the report, the global cell viability assays market size was worth around USD 14.21 billion in 2023 and is predicted to grow to around USD 31.61 billion by 2032.
The global cell viability assays market is expected to grow at a CAGR of 9.29% during the forecast period.
Some key players of the global cell viability assays market are Bio-Rad Laboratories, Inc., GE Healthcare, PerkinElmer, Danaher Corporation, Promega Corporation, Thermo Fisher Scientific, BioTek Instruments, Biotium, Merck, Becton, Dickinson, and Company, and G-Biosciences, among others.
The global cell viability assays market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
HappyClients
